Instituto Bioclon

The Instituto Bioclon S.A. de C.V. (Bioclon Institute) was formed in 1990 to research and develop F(ab’)2 antivenoms.

This institution lacks seriousness, its web page does not exist anymore.

This is what the FDA says about them:

https://www.fda.gov/iceci/enforcementactions/warningletters/2014/ucm394488.htm

Operations

The Instituto Bioclon is located in Mexico City, Mexico and has a Certificación Internacional de Buenas Prácticas de Manufactura (International Certificate for Good Manufacturing Practices) which was granted to Bioclon by the Instituto Nacional de Vigilancia de Medicamentos y Alimentos, (INVIMA) (National Food and Drug Monitoring Institute), of the Ministerio de la Protección Social (Secretary of Social Protection) of Colombia, as well as by COFEPRIS, in Mexico.

Products

• Coralmyn® - coral snake antivenom^[1]
• Antivipmyn® - pit viper antivenom
• Antivipmyn® TRI – Central and South American snakes
• Antivipmyn® Africa – African snakes
• Alacramyn® - scorpion antivenom
• Reclusmyn® - brown recluse antivenom
• Aracmyn® - black widow antivenom

The Bioclon Institute is the only Mexican company that has obtained an "orphan drug" status from the Food and Drug Administration (FDA) of the United States for three of its products.

References

External links

• Instituto Bioclon
• Food and Drug Administration